For many years, many researches suspected that some bacteria could be involved in the development of many cancers. For example, the scientific community has been researching about which mechanism could be involved in the development of colorectal cancer by the Fusobacterium nucleatum bacteria. The bacterium usually appears in the microbial ecosystem of these tumors in the large intestine. In addition, an international team of scientists has discovered that these bacteria could travel with the tumor cells that generate metastasis in the liver. This data suggest that more than a travel companion, they act as drivers of the metastasis.
The Nuciforo team has detected that the bacteria Fusobacterium is in the 70% of all the colorectal tumor samples collected in humans. In the hepatic metastasis of these primary tumors also appears the same strains of bacteria, actually inside of the tumor cells. The team assumes that If there was not a relationship, they would not be able to see the same microbial flora in both tumors tested: colon and colorectal. The authors of the work published in the Science magazine, inserted these human tumors into mice and treated with antibiotics usually used for urethra and vagina infections. The antibiotic by itself accomplished to stop 30% of the tumor development in the mice.
Between the stomach cancer and the bacteria Helicobacter pylori, the Nuciforo team found the same relationship. In fact, the bacteria is considered the main cause of gastric cancer. Nowadays, researchers have been looking for the potential role of this microorganism. Thanks to these results, in further years a new strategy can be developed to treat these types of cancers. A combination with chemotherapy and antibiotics would generate better rates of survival.
In Althian we know that new approaches are developed to treat so many different diseases. We know the importance to understand every detail of the protocol, so we can generate reliable data. We are committed to do our best because we know that some follow ups can take years, so we create a strong relationship to the patients and this leads to not losing them during the Follow Up period. Contact us, and we will be more than happy to run your next clinical.